Boston Scientific Faces Shareholder Lawsuit

Bernstein Liebhard LLP files class action against medical device company over alleged misconduct.

Apr. 2, 2026 at 6:33pm

Got story updates? Submit your updates here. ›

A highly detailed, photorealistic studio still-life image showing a shiny metal medical device component resting on a clean, monochromatic background, conveying a sense of corporate strategy and risk.A shareholder lawsuit alleges that Boston Scientific concealed issues with its medical devices, exposing the company to financial and regulatory risks.NYC Today

Bernstein Liebhard LLP, a prominent national law firm, has filed a class action lawsuit against Boston Scientific Corporation (BSX) on behalf of the company's shareholders. The lawsuit alleges that Boston Scientific engaged in misconduct and made misleading statements that caused financial harm to investors.

Why it matters

As one of the world's largest medical device manufacturers, Boston Scientific's legal troubles could have significant implications for the broader healthcare industry. The shareholder lawsuit raises concerns about corporate governance and transparency, which are important issues for investors to monitor.

The details

The lawsuit alleges that Boston Scientific failed to disclose issues with the manufacturing and safety of certain medical devices, leading to regulatory actions and financial losses for the company. Specifically, the lawsuit claims that Boston Scientific misled investors about problems with its Lotus Valve System, a heart valve replacement product that was eventually recalled.

  • The class action lawsuit was filed on April 2, 2026.
  • The alleged misconduct and misleading statements by Boston Scientific occurred between January 1, 2024 and March 15, 2026.

The players

Bernstein Liebhard LLP

A nationally acclaimed law firm that specializes in class action lawsuits and has filed the shareholder lawsuit against Boston Scientific.

Boston Scientific Corporation (BSX)

A leading global medical device company that manufactures a wide range of products, including the Lotus Valve System that is at the center of the shareholder lawsuit.

Got photos? Submit your photos here. ›

What they’re saying

“Boston Scientific's alleged misconduct has caused significant financial harm to its shareholders, and we are committed to holding the company accountable.”

— Stanley D. Bernstein, Managing Partner, Bernstein Liebhard LLP

What’s next

The lawsuit is currently in the early stages, and the court will determine whether to certify the class in the coming months.

The takeaway

This shareholder lawsuit highlights the importance of transparency and accountability in the medical device industry, where product safety and regulatory compliance are critical. The outcome of this case could set a precedent for how companies in this sector handle issues with their products and communicate with investors.